# Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)

> **NCT01282450** · PHASE2 · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 60 (estimated)

## Conditions studied

- Stage IV (Oligo-metastases)
- Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT01282450
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01282450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01282450, "Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01282450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*